Skip to content

Europe’s most active early-stage healthtech investors – Sifted

Europe’s most active early-stage healthtech investors – Sifted

There are reasons for early-stage European healthtechs to be cheerful in 2023. They’ve raised $7.7bn in funding so far, according to Dealroom. While that figure’s dipped from the $12.5bn picked up across a frothy 2022, it’s fallen far less proportionally than European VC as a whole.And there are signs the sector is on the up. The second quarter of the year saw startups pick up $1.5bn — the best three month period since the last quarter of 2021. The reporting lag — where smaller rounds don’t get factored into funding figures until further down the line — means that number is likely… 

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *